PacificHealth Laboratories Inc
PacificHealth Laboratories, Inc. engages in the development of nutritional products that enhance health and athletic performance in the United States and internationally. It primarily focuses on sports performance, hydration, fueling, and muscle recovery. The company provides ENDUROX R4, a muscle recovery drink; ACCELERADE protein powered sports drink; ACCEL GEL, a energy gel; Body Glove Surge; E… Read more
PacificHealth Laboratories Inc (PHLI) - Total Assets
Latest total assets as of September 2012: $1.99 Million USD
Based on the latest financial reports, PacificHealth Laboratories Inc (PHLI) holds total assets worth $1.99 Million USD as of September 2012.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
PacificHealth Laboratories Inc - Total Assets Trend (1996–2011)
This chart illustrates how PacificHealth Laboratories Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
PacificHealth Laboratories Inc - Asset Composition Analysis
Current Asset Composition (December 2011)
PacificHealth Laboratories Inc's total assets of $1.99 Million consist of 98.0% current assets and 2.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 39.5% |
| Accounts Receivable | $369.38K | 19.5% |
| Inventory | $571.40K | 30.2% |
| Property, Plant & Equipment | $26.73K | 1.4% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1996–2011)
This chart illustrates how PacificHealth Laboratories Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: PacificHealth Laboratories Inc's current assets represent 98.0% of total assets in 2011, an increase from 95.2% in 1996.
- Cash Position: Cash and equivalents constituted 39.5% of total assets in 2011, up from 16.7% in 1996.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1996.
- Asset Diversification: The largest asset category is inventory at 30.2% of total assets.
PacificHealth Laboratories Inc Competitors by Total Assets
Key competitors of PacificHealth Laboratories Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Lonkey Industrial Co Ltd Guangzhou
SHE:000523
|
China | CN¥3.66 Billion |
|
Taiyen Biotech Co Ltd
TW:1737
|
Taiwan | NT$8.26 Billion |
|
Tianjin Yiyi Hygiene Products Co Ltd
SHE:001206
|
China | CN¥2.20 Billion |
|
Hunan Resun Co Ltd
SHE:001218
|
China | CN¥3.08 Billion |
|
Dencare (Chongqing) Oral Care Co. Ltd. A
SHE:001328
|
China | CN¥1.90 Billion |
|
Qingdao Kingking Applied Chemistry Co Ltd
SHE:002094
|
China | CN¥3.19 Billion |
|
C&S Paper Co Ltd
SHE:002511
|
China | CN¥9.17 Billion |
|
Anhui Deli Household Glass Co Ltd
SHE:002571
|
China | CN¥3.08 Billion |
PacificHealth Laboratories Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - PacificHealth Laboratories Inc generates 3.66x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - PacificHealth Laboratories Inc is currently not profitable relative to its asset base.
PacificHealth Laboratories Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.58 | 2.64 | 4.33 |
| Quick Ratio | 0.94 | 1.94 | 2.42 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $676.05K | $ 1.66 Million | $ 3.50 Million |
PacificHealth Laboratories Inc - Advanced Valuation Insights
This section examines the relationship between PacificHealth Laboratories Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.71 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 32.6% |
| Total Assets | $1.89 Million |
| Market Capitalization | $0.92 USD |
Valuation Analysis
Below Book Valuation: The market values PacificHealth Laboratories Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: PacificHealth Laboratories Inc's assets grew by 32.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for PacificHealth Laboratories Inc (1996–2011)
The table below shows the annual total assets of PacificHealth Laboratories Inc from 1996 to 2011.
| Year | Total Assets | Change |
|---|---|---|
| 2011-12-31 | $1.89 Million | +32.65% |
| 2010-12-31 | $1.43 Million | -43.97% |
| 2009-12-31 | $2.54 Million | -24.55% |
| 2008-12-31 | $3.37 Million | -28.87% |
| 2007-12-31 | $4.74 Million | -8.99% |
| 2006-12-31 | $5.21 Million | +67.01% |
| 2005-12-31 | $3.12 Million | +21.02% |
| 2004-12-31 | $2.58 Million | -28.89% |
| 2003-12-31 | $3.62 Million | +33.49% |
| 2002-12-31 | $2.72 Million | -45.83% |
| 2001-12-31 | $5.01 Million | +96.15% |
| 2000-12-31 | $2.56 Million | -8.75% |
| 1999-12-31 | $2.80 Million | -36.36% |
| 1998-12-31 | $4.40 Million | -38.89% |
| 1997-12-31 | $7.20 Million | +71.43% |
| 1996-12-31 | $4.20 Million | -- |